Dr. Greg Hobelmann currently serves as a Co CEO of Ashley Addiction Treatment. In this role, he oversees the clinical, medical and nursing staff for both the inpatient and outpatient clinics, in addition to general operations. He previously worked as an interventional pain specialist as well as a staff psychiatrist after completing his psychiatry residency at Johns Hopkins. He completed an anesthesiology residency and pain medicine fellowship at Johns Hopkins in 2006 and has a Master of Public Health from the Johns Hopkins Bloomberg School of Public Health. His treatment interests include substance use disorder and chronic pain.